SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 01, 17:00
564.95
-14.2 (-2.45%)
VOLUME 183,606
LIVE
NSE
Aug 01, 17:00
565.95
-12.9 (-2.23%)
VOLUME 1,382,084
Business News on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Ranbaxy inks pact with Cipher to sell acne drug in Brazil

7.13 pm | 24 Jul 2014 |  Source: PTI

The licensing agreement extends Ranbaxy's current relationship with Cipher, under which it is marketing isotretinoin capsules in the US under the bran...

How new price control list impacts Indian pharma cos

10.42 am | 23 Jul 2014 |  Source: Moneycontrol.com

With DPCO coverage extending to almost about 40 percent of the industry, the profitability in the domestic business of pharma companies is likely to c...

See lot of good M&A deals in H2 2014 too: Grant Thornton 

7.07 pm | 16 Jul 2014 |  Source: Moneycontrol.com

According to Lahiri, pharma and e-commerce have been the big winners in the first half with mega deals like Sun Pharma acquiring Ranbaxy and Flipkart ...

Price control debate: Is the pharma sector crying 'wolf'? 

6.25 pm | 16 Jul 2014 |  Source: CNBC-TV18

CNBC-TV18's Shereen Bhan spoke to Kiran Mazumdar Shaw, CMD of Biocon and CM Gulati is Editor, Monthly Index of Medical Specialities (MIMS) to get thei...

See more drug price caps; max impact on Sanofi: Expert 

10.09 am | 16 Jul 2014 |  Source: CNBC-TV18

NPPA has cut and capped prices of some major anti-diabetes and cardiovascular drugs that were not part of the 652 drugs earlier listed out by the gove...

Anti-diabetes, cardiovascular drugs to get upto 35% cheaper 

4.45 pm | 14 Jul 2014 |  Source: CNBC-TV18

NPPA has cut and capped prices of some major anti-diabetes and cardiovascular drugs that were not part of the 652 drugs earlier listed out by the gove...

See prices of cardiac drugs reduce by 15-50%: Ex-MD Pfizer 

12.12 pm | 14 Jul 2014 |  Source: CNBC-TV18

According to Kewal Handa, the pricing regulator (NPPA) has fixed prices of medicines that are not included in the national list of essential medicines...

Sun-Ranbaxy deal pushes domestic H1, M&As jump 22%

6.12 pm | 03 Jul 2014 |  Source: PTI

The average M&A deal size climbed to USD 95 million during the reporting period from USD 62.8 million the same period last year....

Will look to close Ranbaxy deal by year-end: Sun Pharma 

2.00 pm | 30 Jun 2014 |  Source: CNBC-TV18

According to Uday Baldota of Sun Pharma winning CNBC-TV18's CFO award in the pharma and healthcare space is recognition of the company's good performa...

GDUFA fee: 86 generic drug approvals voluntarily withdrawn

10.10 pm | 27 Jun 2014 |  Source: CNBC-TV18

Drug companies in the US are carefully evaluating their portfolios to give away approvals for those products that are not commercially viable, as thes...

Nexium generic next big opportunity for Ranbaxy: Angel 

3.02 pm | 27 Jun 2014 |  Source: CNBC-TV18

Given the Sun-Ranbaxy merger, Nangra sees an upside potential of 8-10 percent in Ranbaxy....

USFDA boost for Ranbaxy; see akin deal for Nexium: Dandekar 

9.08 am | 27 Jun 2014 |  Source: CNBC-TV18

After a long stretch of regulatory hassles, Vikas Dandekar of PharmAsiaNews.Com believes the worst is behind for the pharma major with this USFDA boos...

FDA approves Ranbaxy's generic version of Novartis's Diovan

8.25 am | 27 Jun 2014 |  Source: Reuters

Novartis lost its patent rights to Diovan in the United States at the end of 2012 but has avoided generic competition because of multiple quality cont...

Indian, US generic cos launch Coalition for Affordable Care

3.00 pm | 26 Jun 2014 |  Source: PTI

This is to take head on big American pharmaceutical giants, which in the recent past had launched a strong anti-India campaign against efforts of such...

Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.